Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT trialsAditi A Kharat, Richard Nelson, Trang Au, et al.Journal of Comparative Effectiveness Research|March 18, 2024
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methodsJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Journal of Pain & Palliative Care Pharmacotherapy|April 19, 2012
A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathyBrandon K Bellows, Arati Dahal, Tianze Jiao, et al.Journal of Managed Care Pharmacy : JMCP|October 26, 2013
Cost implications of formulary decisions on oral anticoagulants in nonvalvular atrial fibrillationJoseph Biskupiak, Sameer R Ghate, Tianze Jiao, et al.Journal of Medical Economics|February 22, 2013
Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcomaKarina Raimundo, Joseph Biskupiak, Michael Goodman, et al.Oncology Research and Treatment|July 27, 2021
Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect ComparisonAditi Kharat, Madeline Brendle, Anindit Chhibber, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 30, 2024
An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19Daniel C Malone, Joseph Biskupiak, Diana Brixner, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2007
Antiplatelet medication management in patients hospitalized with ischemic strokeNancy A Nickman, Joseph Biskupiak, Freddy Creekmore, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
Payer perceptions on the use of economic models in oncology decision makingJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Journal of the American Pharmacists Association : Japha|March 8, 2021
Association of pharmacist counseling with adherence, 30-day readmission, and mortality: A systematic review and meta-analysis of randomized trialsWilliam N Kelly, Mei-Jen Ho, Krystal Bullers, et al.Pageof 6